文章来源:医疗器械商业评论美敦力旗下的糖尿病技术子公司MiniMed已正式登陆纳斯达克,股票代码为“MMED”,标志着这家拥有40余年历史的糖尿病技术公司重返独立运营轨道。本次IPO发行2800万股,每股定价20美元,总募资金额达5.6亿美元。这一发行价低于该公司上个月在文件中初步建议的每股25至28美元的区间。根据雅虎财经数据,MiniMed上市后的市值约为52.9亿美元(约合人民币365亿)。...
Source Link文章来源:医疗器械商业评论美敦力旗下的糖尿病技术子公司MiniMed已正式登陆纳斯达克,股票代码为“MMED”,标志着这家拥有40余年历史的糖尿病技术公司重返独立运营轨道。本次IPO发行2800万股,每股定价20美元,总募资金额达5.6亿美元。这一发行价低于该公司上个月在文件中初步建议的每股25至28美元的区间。根据雅虎财经数据,MiniMed上市后的市值约为52.9亿美元(约合人民币365亿)。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.